Compare FENC & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FENC | EAF |
|---|---|---|
| Founded | 1996 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.8M | 236.5M |
| IPO Year | 2010 | 2018 |
| Metric | FENC | EAF |
|---|---|---|
| Price | $9.04 | $8.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $14.50 | $11.75 |
| AVG Volume (30 Days) | ★ 263.7K | 245.7K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | $44,642,000.00 | ★ $504,134,000.00 |
| Revenue This Year | $65.12 | $4.25 |
| Revenue Next Year | $41.08 | $12.49 |
| P/E Ratio | $906.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.65 | $0.93 |
| 52 Week High | $10.45 | $20.32 |
| Indicator | FENC | EAF |
|---|---|---|
| Relative Strength Index (RSI) | 54.46 | 39.93 |
| Support Level | $8.25 | $7.70 |
| Resistance Level | $9.15 | $7.73 |
| Average True Range (ATR) | 0.49 | 0.81 |
| MACD | -0.12 | -0.20 |
| Stochastic Oscillator | 36.21 | 5.56 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products used as raw material in the production of graphite electrodes.